BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7870572)

  • 1. The c-myc protein represses the lambda 5 and TdT initiators.
    Mai S; Mårtensson IL
    Nucleic Acids Res; 1995 Jan; 23(1):1-9. PubMed ID: 7870572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional down-regulation of CXC chemokine receptor 4 induced by impaired association of transcription regulator YY1 with c-Myc in human herpesvirus 6-infected cells.
    Hasegawa A; Yasukawa M; Sakai I; Fujita S
    J Immunol; 2001 Jan; 166(2):1125-31. PubMed ID: 11145693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation.
    Prendergast GC; Lawe D; Ziff EB
    Cell; 1991 May; 65(3):395-407. PubMed ID: 1840505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max.
    Gu W; Cechova K; Tassi V; Dalla-Favera R
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2935-9. PubMed ID: 8385351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity.
    Ayer DE; Kretzner L; Eisenman RN
    Cell; 1993 Jan; 72(2):211-22. PubMed ID: 8425218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).
    Kyo S; Takakura M; Taira T; Kanaya T; Itoh H; Yutsudo M; Ariga H; Inoue M
    Nucleic Acids Res; 2000 Feb; 28(3):669-77. PubMed ID: 10637317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
    Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S
    J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R; Chen JM; Huard S; Wang E
    J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of DNA binding of the c-Myc/Max and ARNT/ARNT dimers at the CACGTG recognition site.
    Swanson HI; Yang JH
    Nucleic Acids Res; 1999 Aug; 27(15):3205-12. PubMed ID: 10454619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression.
    Si J; Yu X; Zhang Y; DeWille JW
    Mol Cancer; 2010 Apr; 9():92. PubMed ID: 20426839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site.
    Hann SR; Dixit M; Sears RC; Sealy L
    Genes Dev; 1994 Oct; 8(20):2441-52. PubMed ID: 7958908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ectopic expression of myc or myn down-regulates immunoglobulin transcription.
    Sigvardsson M; Johansson K; Larsson LG; Nilsson K; Leanderson T
    Leukemia; 1994 Jul; 8(7):1157-63. PubMed ID: 8035607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo.
    James L; Eisenman RN
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10429-34. PubMed ID: 12149476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K; Anand G; Yin X; Grove L; Prochownik EV
    Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation.
    Reddy CD; Dasgupta P; Saikumar P; Dudek H; Rauscher FJ; Reddy EP
    Oncogene; 1992 Oct; 7(10):2085-92. PubMed ID: 1408152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA binding of Myc/Max/Mad network complexes to oligonucleotides containing two E box elements: c-Myc/Max heterodimers do not bind DNA cooperatively.
    Vervoorts J; Lüscher B
    Biol Chem; 1999 Sep; 380(9):1121-6. PubMed ID: 10543451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc.
    FitzGerald MJ; Arsura M; Bellas RE; Yang W; Wu M; Chin L; Mann KK; DePinho RA; Sonenshein GE
    Oncogene; 1999 Apr; 18(15):2489-98. PubMed ID: 10229200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of c-Myc and Max binding to the c-myc promoter: evidence that autosuppression occurs via an indirect mechanism.
    Buckle RS; Méchali M
    Oncogene; 1995 Mar; 10(6):1249-55. PubMed ID: 7700652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dominant-negative mutant of Max that inhibits sequence-specific DNA binding by Myc proteins.
    Billaud M; Isselbacher KJ; Bernards R
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2739-43. PubMed ID: 8464883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of human ornithine decarboxylase expression by the c-Myc.Max protein complex.
    Peña A; Reddy CD; Wu S; Hickok NJ; Reddy EP; Yumet G; Soprano DR; Soprano KJ
    J Biol Chem; 1993 Dec; 268(36):27277-85. PubMed ID: 8262968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.